Clinical trial

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

NCT01492972

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2012-01-01

PhasePHASE3

Study timeline

Study start (unknown)2012-01-01Date precision: month

Registry last updated2026-09-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

RadiationRADIATION

Androgen Suppression TherapyDRUG

Sponsors & collaborators

Proton Collaborative Grouplead sponsor

Mapped research locations

Oklahoma CityOklahoma, United States1 ScottsdaleArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01492972 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.